BrightView Holdings, Inc., through its subsidiaries, provides commercial landscaping services in the United States. It operates in two segments, Maintenance Services and Development Services. The Maintenance Services segment delivers a suite of recurring commercial landscaping services, including mowing, gardening, mulching and snow removal, water management, irrigation maintenance, tree care, golf course maintenance, and specialty turf maintenance. Its customers' properties include corporate and commercial properties, homeowners associations, public parks, hotels and resorts, airport authorities, municipalities, hospitals and other healthcare facilities, educational institutions, restaurants and retail, and golf courses. This segment's customer base includes approximately 11,700 office parks and corporate campuses 10,000 residential communities, and 700 educational institutions. The Development Services segment offers landscape architecture and development services for new facilities and redesign projects. Its services include project design and management services, landscape architecture and installation, irrigation installation, tree moving and installation, pool and water features, sports field, and other services. BrightView Holdings, Inc. also operates as official field consultant to Major League Baseball. The company was formerly known as BrightView Acquisition Holdings, Inc. BrightView Holdings, Inc. was founded in 1939 and is headquartered in Blue Bell, Pennsylvania.

BrightView Holdings Inc.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on DBV Technologies SA – American (DBVT) and Kalaris Th...

Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT) and Kalaris Therapeutics (KLRS)

The latest announcement is out from Vistry Group ( ($GB:VTY) ). Vistry Group PLC reported that its Executive Chair, Daniel King, increased his hold...

Vistry Executive Chair Adds Shares Through Incentive Plan

In a report released today, Ignacio Cerezo from UBS assigned a Hold rating to Banco Bilbao Vizcaya Argentaria, with a price target of €22.00. Cerez...

Banco Bilbao Vizcaya Argentaria (BVA) Gets a Hold from UBS

Banco Bilbao Vizcaya Argentaria received a Hold rating and a €25.00 price target from Bank of America Securities analyst Antonio Reale today. Accor...

Banco Bilbao Vizcaya Argentaria (BVA) was downgraded to a Hold Rating at Bank of America Securities

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Fractyl Health, Inc. (GUTS) and AbbVie (ABBV) with b...

Analysts Are Bullish on Top Healthcare Stocks: Fractyl Health, Inc. (GUTS), AbbVie (ABBV)

In a report released yesterday, Cecilia Romero from Barclays assigned a Hold rating to Banco Bilbao Vizcaya Argentaria. The company’s shares opened...

Banco Bilbao Vizcaya Argentaria (BVA) Gets a Hold from Barclays

In a report released on July 13, Cameron Halkett from Canaccord Genuity maintained a Buy rating on Bravura Solutions Limited, with a price target o...

Canaccord Genuity Reaffirms Their Buy Rating on Bravura Solutions Limited (BVS)

In a report released today, Inigo Vega from Jefferies maintained a Buy rating on Banco Bilbao Vizcaya Argentaria, with a price target of €27.00. Ac...

Jefferies Sticks to Its Buy Rating for Banco Bilbao Vizcaya Argentaria (BVA)

The latest update is out from Itau Unibanco ( ($ITUB) ). Itaú Unibanco Holding S.A., a leading Brazilian universal bank with significant retail, co...

Itaú Unibanco to Repurchase BRL 1.4 Billion in Tier 1 Subordinated Bills

An announcement from Vistry Group ( ($GB:VTY) ) is now available. Vistry Group PLC has disclosed a share purchase by independent non-executive dire...

Vistry Non-Executive Director Boosts Stake with Share Purchase

An announcement from Banco Bilbao ( ($BBVA) ) is now available. BBVA has provided an update on the execution of the third tranche of its share buyb...

BBVA Advances Third Tranche of €1.46 Billion Share Buyback Program

Macquarie analyst maintained a Hold rating on Bravura Solutions Limited today and set a price target of A$2.34. Bravura Solutions Limited has an an...

Bravura Solutions Limited (BVS) Receives a Hold from Macquarie

Top Glove Bhd ( ($TPGVF) ) has provided an announcement. Top Glove has disclosed a change in the interest of a substantial shareholder, Kumpulan Wa...

Top Glove Reports Share Disposal by Major Investor KWAP

Canaccord Genuity analyst Cameron Halkett maintained a Buy rating on Bravura Solutions Limited on July 9 and set a price target of A$2.73. The comp...

Bravura Solutions Limited (BVS) Gets a Buy from Canaccord Genuity

Stocks ended the week higher as continued enthusiasm for AI and technology shares helped lift the major U.S. indexes. The Dow Jones Industrial Aver...

The Week That Was, The Week Ahead: Macro and Markets, July 12

AbbVie ($ABBV) and Abbott Laboratories ($ABT) are two Dividend Aristocrat stocks with a Strong Buy consensus rating on Wall Street and an ex-divide...

2 ‘Strong Buy’ Dividend Aristocrat Stocks to Grab Right Now for August Payouts

Analysts have been eager to weigh in on the Industrial Goods sector with new ratings on BrightView Holdings (BV) and Canadian Pacific Kansas City (...

Analysts’ Opinions Are Mixed on These Industrial Goods Stocks: BrightView Holdings (BV) and Canadian Pacific Kansas City (CP)

The latest announcement is out from Top Glove Bhd ( ($TPGVF) ). Top Glove Corporation Bhd has announced a change in the interest of a substantial s...

KWAP Trims Indirect Stake in Top Glove, Remains Major Shareholder

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on AbbVie (ABBV) and Eli Lilly & Co (LLY) with bullish ...

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Eli Lilly & Co (LLY)

In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Buy rating on AbbVie, with a price target of $295.00. The company’s shar...

Wells Fargo Sticks to Their Buy Rating for AbbVie (ABBV)

Bravura Solutions Limited ( ($AU:BVS) ) has issued an announcement. Bravura Solutions Limited has notified the market of the issue or conversion of...

Bravura Issues Notice on Conversion of Unquoted Equity Securities

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Tyra Bioscience (TYRA), Corcept Therapeutics (CORT) ...

Analysts Are Bullish on These Healthcare Stocks: Tyra Bioscience (TYRA), Corcept Therapeutics (CORT)

In a report released yesterday, Anthony Codling from RBC Capital maintained a Sell rating on Vistry Group, with a price target of p180.00. Codling ...

Vistry Group (VTY) Receives a Sell from RBC Capital

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) has completed a first‑in‑human study called “A First‑in‑Human Sin...

AbbVie’s ABBV‑277 Trial Completion: What Early Safety Data Could Mean for Investors

An update from Itau Unibanco ( ($ITUB) ) is now available. On July 7, 2026, Itaú Unibanco Holding S.A. filed a Form 6-K in the United States formal...

Itaú Unibanco Sets Stricter Share-Based Pay Rules for Executives in New Policy Filing

The latest update is out from Itau Unibanco ( ($ITUB) ). On July 7, 2026, Itaú Unibanco filed a Form 6-K in the United States to publicly disclose ...

Itaú Unibanco Updates U.S. Market on Integrated Compliance and Operational Risk Policy

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Atai Beckley N.V. (ATAI), Bioventus (BVS) and Crin...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Atai Beckley N.V. (ATAI), Bioventus (BVS) and Crinetics Pharmaceuticals (CRNX)

Scotiabank analyst Louise Chen maintained a Buy rating on AbbVie today and set a price target of $280.00. Chen covers the Healthcare sector, focusi...

Scotiabank Sticks to Its Buy Rating for AbbVie (ABBV)

Bellavista Resources Ltd ( ($AU:BVR) ) has issued an update. Franklin Resources, Inc. and its affiliates have filed notice that they have ceased to...

Franklin Resources Falls Below Substantial Holder Threshold in Bellavista Resources

Baronsmead Venture ( ($GB:BVT) ) has shared an update. Baronsmead Venture Trust PLC has updated the market on its share capital and voting rights a...

Baronsmead Venture Trust Updates Share Capital and Voting Rights

Wedbush analyst David Nierengarten maintained a Hold rating on Abivax SA Sponsored ADR today and set a price target of $140.00. According to TipRan...

Abivax SA Sponsored ADR (ABVX) Gets a Hold from Wedbush

Barrington analyst Michael Petusky maintained a Buy rating on Bioventus today and set a price target of $14.00. According to TipRanks, Petusky is a...

Barrington Remains a Buy on Bioventus (BVS)

Banco Bilbao Vizcaya Argentaria ( ($ES:BBVA) ) just unveiled an update. BBVA has announced a significant corporate action in the form of a share bu...

BBVA Announces Share Buyback Program

J.P. Morgan analyst Marta Sanchez Romero maintained a Buy rating on Banco Bilbao Vizcaya Argentaria on July 3 and set a price target of €23.40. The...

Banco Bilbao Vizcaya Argentaria (BVA) Gets a Buy from J.P. Morgan

Breville Group ( ($AU:BRG) ) has provided an announcement. Breville Group Limited has disclosed that 19,368 performance rights, previously on issue...

Breville Performance Rights Lapse After Unmet Conditions

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie’s latest update covers a post‑market study on its CoolSculpting Elite de...

AbbVie’s CoolSculpting Elite Study Update Strengthens Aesthetics Outlook

Abbvie ($ABBV) announced an update on their ongoing clinical study. The Phase 2 trial NCT05660967 tests epcoritamab with or without lenalidomide as...

Trial Termination Shifts Outlook for AbbVie’s Epcoritamab in Frontline Lymphoma

Itau Unibanco ( ($ITUB) ) has shared an update. On July 1, 2026, Itaú Unibanco announced that it has won a new bidding process run by the Governmen...

Itaú Unibanco Secures New Five-Year Payroll Deal with Minas Gerais

Bellavista Resources Ltd ( ($AU:BVR) ) just unveiled an update. Bellavista Resources has commenced drilling campaigns in both Canada and Australia ...

Bellavista launches new drilling in Canada and Australia with strong funding base

The latest update is out from Banco Bilbao Vizcaya Argentaria ( ($ES:BBVA) ). BBVA has announced the launch of a share buyback program, as disclose...

BBVA Announces Launch of Share Buyback Program

In a report released yesterday, Yatin Suneja from Guggenheim maintained a Buy rating on DBV Technologies SA – American, with a price target of $51....

Guggenheim Sticks to Their Buy Rating for DBV Technologies SA – American (DBVT)

In a report released on June 29, Karl Green CFA from RBC Capital maintained a Hold rating on Bureau Veritas, with a price target of €26.00. The com...

RBC Capital Sticks to Their Hold Rating for Bureau Veritas (0MH1)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Genelux Corp. (GNLX) and Abivax SA Sponsored ADR (AB...

Wall Street Analysts Are Bullish on Top Healthcare Picks

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on HeartFlow, Inc. (HTFL), Taysha Gene Therapies (TSHA)...

Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (HTFL), Taysha Gene Therapies (TSHA) and Abivax SA Sponsored ADR (ABVX)

The latest announcement is out from Vistry Group ( ($GB:VTY) ). Vistry Group PLC reported that as of 30 June 2026 its issued share capital comprise...

Vistry updates share capital and voting rights structure

Barclays analyst James Rowland Clark maintained a Buy rating on Bureau Veritas today and set a price target of €31.00. According to TipRanks, Rowla...

Barclays Sticks to Its Buy Rating for Bureau Veritas (0MH1)

The latest update is out from Abivax SA Sponsored ADR ( ($ABVX) ). On June 29, 2026, Abivax reported positive topline data from Part 2 of its 44-we...

Abivax Posts Positive Phase 3 Maintenance Data for Obefazimod in Refractory Ulcerative Colitis

An announcement from DBV Technologies SA – American ( ($DBVT) ) is now available. On June 29, 2026, DBV Technologies reported that it has been enga...

DBV Advances VIASKIN Peanut Patch Toward FDA Submission

Abbvie ($ABBV) announced an update on their ongoing clinical study. The FAST study, officially titled “Evaluation of Function And Satisfaction of U...

AbbVie’s FAST Study Wraps Up: Real-World Checkup on Ubrogepant’s Migraine Performance

Stocks ended the week lower as investors pulled back from risk assets and rotated into safer parts of the market. The Dow Jones Industrial Average ...

The Week That Was, The Week Ahead: Macro and Markets, June 28

AbbVie ( ($ABBV) ) has risen by 10.15%. Read on to learn why. AbbVie shares climbed 10.15% over the past week as investors cheered fresh analyst co...

AbbVie Stock Surges as Immunology Bet Ignites Hype

Analysts are intrested in these 5 stocks: ( ($BWXT) ), ( ($ALT) ), ( ($GPN) ), ( ($ABBV) ) and ( ($NKE) ). Here is a breakdown of their recent


BWXT, Altimmune, Global Payments, AbbVie, Nike Trending With Analysts

An announcement from Top Glove Bhd ( ($TPGVF) ) is now available. Top Glove Corporation Bhd disclosed a change in the shareholding of substantial i...

Kumpulan Wang Persaraan Raises Stake in Top Glove via Open-Market Purchase

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on AbbVie (ABBV) and Ionis Pharmaceuticals (IONS) with ...

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Ionis Pharmaceuticals (IONS)

Bellavista Resources Ltd ( ($AU:BVR) ) has issued an update. Bellavista Resources has issued 1,000,000 fully paid ordinary shares following the exe...

Bellavista Resources Raises A$250,000 via Option Exercise and Issues Cleansing Notice

CGS International analyst Lim Siew Khee maintained a Buy rating on Thai Beverage Public Co yesterday and set a price target of S$0.58. The company’...

CGS International Keeps Their Buy Rating on Thai Beverage Public Co (TBVPF)

In a report released yesterday, Greg Palm from Craig-Hallum maintained a Buy rating on BrightView Holdings. The company’s shares closed yesterday a...

Craig-Hallum Sticks to Its Buy Rating for BrightView Holdings (BV)

In a report released on June 22, Trung Huynh from RBC Capital maintained a Buy rating on AbbVie, with a price target of $260.00. The company’s shar...

RBC Capital Sticks to Their Buy Rating for AbbVie (ABBV)

There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Thai Beverage Public Co (TBVPF) and Uni-Presiden...

Analysts Offer Insights on Consumer Goods Companies: Thai Beverage Public Co (OtherTBVPF) and Uni-President China Holdings (OtherUNPSF)

An update from Banco Bilbao Vizcaya Argentaria ( ($ES:BBVA) ) is now available. BBVA has executed a partial share capital reduction approved at its...

BBVA Cancels 52.8 Million Treasury Shares in Capital Reduction

Baronsmead Venture ( ($GB:BVT) ) has provided an announcement. Baronsmead Venture Trust plc has repurchased 6,746,730 of its own ordinary shares at...

Baronsmead Venture Trust Tightens Capital Base With Share Buyback

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) has launched a new early stage trial, NCT07604558, to test a sing...

AbbVie Expands Pipeline With New Bretisilocin Phase 1 Safety Study

The latest announcement is out from Bioventix ( ($GB:BVXP) ). Bioventix plc reported that its Chief Financial Officer, Bruce Hiscock, has increased...

Bioventix CFO Increases Stake with Share Purchase

Thai Beverage Public Co ( ($SG:Y92) ) has provided an announcement. Thai Beverage reported first-half 2026 revenue of THB 173.2 billion, down 2.5% ...

ThaiBev lifts profit margins despite softer 1H26 sales

Top Glove Bhd ( ($TPGVF) ) has issued an announcement. Top Glove Corporation Bhd disclosed a change in the interest of a substantial shareholder, K...

KWAP Boosts Stake in Top Glove with Open-Market Share Acquisition

Banco Bilbao ( ($BBVA) ) has shared an update. BBVA has provided an update on the execution of the third tranche of its share buyback programme, ma...

BBVA Advances Third Tranche of Share Buyback Programme Beyond Halfway Mark

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Taysha Gene Therapies (TSHA) and AbbVie (ABBV) with ...

Analysts Offer Insights on Healthcare Companies: Taysha Gene Therapies (TSHA) and AbbVie (ABBV)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on AbbVie (ABBV) and MapLight Therapeutics, Inc. (MPLT)...

Analysts Are Bullish on Top Healthcare Stocks: AbbVie (ABBV), MapLight Therapeutics, Inc. (MPLT)

Top Glove Bhd ( ($TPGVF) ) has shared an announcement. Kumpulan Wang Persaraan (Diperbadankan), a Malaysian pension fund, has increased its stake i...

Pension Fund KWAP Raises Stake in Top Glove, Signalling Increased Institutional Support

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Tenax Therapeutics (TENX), Abbott Laboratories (ABT)...

Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX), Abbott Laboratories (ABT) and AbbVie (ABBV)

Banco Bilbao Vizcaya Argentaria ( ($ES:BBVA) ) has shared an update. BBVA has announced a significant event relating to a new share buyback program...

BBVA Announces New Share Buyback Program

AbbVie ($ABBV) is reportedly nearing an $11 billion cash deal to acquire Apogee Therapeutics ($APGE), a biotechnology company focused on inflammato...

‘A Solid Fit’: JPMorgan Backs AbbVie’s Potential $11B Apogee Deal

Analysts fell to the sidelines weighing in on AbbVie (ABBV) and Moderna (MRNA) with neutral ratings, indicating that the experts are neither bullis...

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Moderna (MRNA)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AbbVie (ABBV) and Moderna (MRNA). AbbVie (ABBV) J....

Analysts Conflicted on These Healthcare Names: AbbVie (ABBV) and Moderna (MRNA)

Shares in biotechnology company Apogee Therapeutics ($APGE) are set to start the new week off in great shape on reports that it could be swallowed ...

M&A News: AbbVie Lining up an $11B Deal for Eczema Drug Maker Apogee Therapeutics

Top Glove Bhd ( ($TPGVF) ) has issued an update. Malaysia’s retirement fund Kumpulan Wang Persaraan (Diperbadankan) has increased its stake in Top ...

KWAP Raises Substantial Stake in Top Glove Through Open-Market Purchase

Top Glove Bhd ( ($TPGVF) ) has provided an update. Top Glove Corporation Bhd has disclosed share acquisitions by key members of its leadership outs...

Top Glove Top Executives Boost Stakes with RM4.32 Million Share Purchases

Top Glove Bhd ( ($TPGVF) ) has shared an update. Top Glove founder and executive chairman Tan Sri Dr Lim Wee Chai has increased his direct stake in...

Top Glove chairman boosts stake with 2 million-share purchase

Top Glove Bhd ( ($TPGVF) ) has issued an update. Top Glove Corporation Bhd has disclosed a change in the interest of its substantial shareholder, e...

Top Glove Chairman Boosts Stake with Additional Share Purchase

The latest update is out from BrightView Holdings ( ($BV) ). On June 17, 2026, BrightView Holdings, Inc. and its lenders entered into an amendment ...

BrightView Extends Debt Maturities to Support Long-Term Strategy

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie is running a late-stage cancer study called “An Open-Label, Randomized, ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BV	$14.52	-2.22%	638.48K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BV	$14.52	-2.2%	638.48K
3
4
5
6

BV

BV

Get BrightView Holdings Inc. Data in Excel

Get BrightView Holdings Inc. Data in Excel